Related references
Note: Only part of the references are listed.Clinical and molecular characteristics of Chryseobacterium indologenes isolates at a teaching hospital in Shanghai, China
Yixin Zhang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Comparative activities of sitafloxacin against recent clinical isolates in hospitals across China
Shi Wu et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)
Molecular Characteristics and Antimicrobial Susceptibility Profiles of Elizabethkingia Clinical Isolates in Shanghai, China
Leilei Wang et al.
INFECTION AND DRUG RESISTANCE (2020)
Comparative in vitro activities of meropenem in combination with colistin, levofloxacin, or chloramphenicol against Achromobacter xylosoxidans strains isolated from patients with cystic fibrosis
Damla Damar-Celik et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
Antimicrobial susceptibility of non-fermenting Gram-negative pathogens isolated from cystic fibrosis patients
Maria Diez-Aguilar et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Differences in Clinical Manifestations, Antimicrobial Susceptibility Patterns, and Mutations of Fluoroquinolone Target Genes between Chryseobacterium gleum and Chryseobacterium indologenes
Jiun-Nong Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Elizabethkingia Infections in Humans: From Genomics to Clinics
Jiun-Nong Lin et al.
MICROORGANISMS (2019)
Comparison of the therapeutic efficacy of fluoroquinolone and non-fluoroquinolone treatment in patients with Elizabethkingia meningoseptica bacteraemia
Ying-Chi Huang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Comparative in vitro activity of sitafloxacin against bacteremic isolates of carbapenem resistant Acinetobacter baumannii complex
Yu-Shan Huang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2015)
Stenotrophomonas, Achromobacter, and Nonmelioid Burkholderia Species: Antimicrobial Resistance and Therapeutic Strategies
Iain J. Abbott et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Population pharmacokinetics and pharmacodynamics of sitafloxacin in patients with community-acquired respiratory tract infections
Yusuke Tanigawara et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)
Stenotrophomonas maltophilia - The most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: A prospective multicenter study
Vincent Fihman et al.
JOURNAL OF INFECTION (2012)
In Vitro Antimicrobial Activity of Last-Resort'' Antibiotics Against Unusual Nonfermenting Gram-Negative Bacilli Clinical Isolates
Herve Jacquier et al.
MICROBIAL DRUG RESISTANCE (2012)
Sitafloxacin In Bacterial Infections
Gillian M. Keating
DRUGS (2011)
Non-fermentative Gram-negative bacteria
D. A. Enoch et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Pharmacokinetics and absolute bioavailability of sitafloxacin, a new fluoroquinolone antibiotic, in healthy male and female Caucasian subjects
J O'Grady et al.
XENOBIOTICA (2001)
Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping
S Brisse et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2000)
Typing of 154 clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and determination of the in vitro susceptibilities of these strains to 28 antibiotics
FJ Schmitz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Share Paper
